Paladin Advisory Group, LLC - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 41 filers reported holding LUMOS PHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Paladin Advisory Group, LLC ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q3 2023$14,4770.0%4,3870.0%0.01%0.0%
Q2 2023$14,477
-0.3%
4,3870.0%0.01%0.0%
Q1 2023$14,521
-8.3%
4,3870.0%0.01%
-14.3%
Q4 2022$15,837
-58.3%
4,387
+0.1%
0.01%
-60.0%
Q3 2022$38,000
+15.2%
4,3820.0%0.04%
+25.0%
Q2 2022$33,000
-17.5%
4,3820.0%0.03%
-15.2%
Q1 2022$40,000
+33.3%
4,3820.0%0.03%
+37.5%
Q4 2021$30,0004,3820.02%
Other shareholders
LUMOS PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
Acuitas Investments, LLC 153,867$507,7610.30%
Lion Point Capital, LP 78,351$258,5580.12%
Minerva Advisors LLC 26,549$840.06%
Wealth Advisors of Iowa, LLC 11,699$38,6060.03%
Marquette Asset Management, LLC 31,088$102,5910.02%
Greenwich Wealth Management LLC 49,002$1620.02%
Key FInancial Inc 10,927$36,0590.01%
Paladin Advisory Group, LLC 4,387$14,4770.01%
Blackstone Inc. 468,145$1,544,8790.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$157,2220.00%
View complete list of LUMOS PHARMA INC shareholders